Related Experiment Video
Updated: Sep 23, 2025

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation
Beate Vajen1, Rahul Bhowmick2, Luisa Greiwe1
1Department of Human Genetics, Hannover Medical School, Carl-Neuberg-Str. 1, 30629 Hannover, Germany.
Abstract:
Chromosomal instability (CIN) can be a driver of tumorigenesis but is also a promising therapeutic target for cancer associated with poor prognosis such as triple negative breast cancer (TNBC). The treatment of TNBC cells with defects in DNA repair genes with poly(ADP-ribose) polymerase inhibitor (PARPi) massively increases CIN, resulting in apoptosis. Here, we identified a previously unknown role of microRNA-449a in CIN. The transfection of TNBC cell lines HCC38, HCC1937 and HCC1395 with microRNA-449a mimics led to induced apoptosis, reduced cell proliferation, and reduced expression of genes in homology directed repair (HDR) in microarray analyses. EME1 was identified as a new target gene by immunoprecipitation and luciferase assays. The reduced expression of EME1 led to an increased frequency of ultrafine bridges, 53BP1 foci, and micronuclei. The induced expression of microRNA-449a elevated CIN beyond tolerable levels and induced apoptosis in TNBC cell lines by two different mechanisms: (I) promoting chromatid mis-segregation by targeting endonuclease EME1 and (II) inhibiting HDR by downregulating key players of the HDR network such as E2F3, BIRC5, BRCA2 and RAD51. The ectopic expression of microRNA-449a enhanced the toxic effect of PARPi in cells with pathogenic germline BRCA1 variants. The newly identified role makes microRNA-449a an interesting therapeutic target for TNBC.
Insights
MicroRNA-449a induces apoptosis in triple-negative breast cancer (TNBC) by increasing chromosomal instability (CIN). This microRNA targets EME1 and inhibits DNA repair, offering a new therapeutic strategy for TNBC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chromosomal instability (CIN) drives tumorigenesis and is a therapeutic target in triple-negative breast cancer (TNBC).
- Poly(ADP-ribose) polymerase inhibitors (PARPi) increase CIN in DNA repair-deficient TNBC cells, leading to apoptosis.
Purpose of the Study:
- To investigate the role of microRNA-449a in chromosomal instability (CIN) and its therapeutic potential in triple-negative breast cancer (TNBC).
Main Methods:
- Transfection of TNBC cell lines with microRNA-449a mimics.
- Microarray analysis to assess gene expression changes.
- Immunoprecipitation and luciferase assays to identify target genes.
- Analysis of chromosomal aberrations (ultrafine bridges, 53BP1 foci, micronuclei).
Main Results:
- MicroRNA-449a mimics induced apoptosis, reduced proliferation, and decreased homology-directed repair (HDR) gene expression in TNBC cells.
- EME1 was identified as a direct target of microRNA-449a, and its downregulation increased chromosomal instability.
- MicroRNA-449a induced apoptosis via chromatid mis-segregation (targeting EME1) and HDR inhibition (downregulating E2F3, BIRC5, BRCA2, RAD51).
- Ectopic microRNA-449a expression enhanced PARPi toxicity in cells with BRCA1 variants.
Conclusions:
- MicroRNA-449a plays a novel role in inducing chromosomal instability (CIN) and apoptosis in triple-negative breast cancer (TNBC).
- MicroRNA-449a represents a potential therapeutic target for TNBC, particularly in combination with PARPi therapy for BRCA1-mutated cancers.
Related Concept Videos
MicroRNAs
Drugs that Destabilize Microtubules
DNA Damage can Stall the Cell Cycle
Drugs that Stabilize Microtubules
Abnormal Proliferation
Negative Regulator Molecules

